Picture of Omnicell logo

OMCL Omnicell News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Healthcare tech cos well-positioned to tackle labor crunch - JPM

** J.P.Morgan analyst Anne Samuel says healthcare tech firms
Phreesia Inc  PHR.N , R1 RCM Inc  RCM.O , Omnicell Inc  OMCL.O 
and Health Catalyst Inc  HCAT.O  are key players that should
benefit from healthcare labor shortages
    ** COVID accelerated the labor headwinds healthcare industry
was facing due to an aging U.S. population, which increases the
need for care while reducing the labor force
    ** Samuel views healthcare technology companies as
well-positioned to tackle labor shortage in the long term
through automating and streamlining workforce performance
    ** PHR, RCM, OMCL and HCAT should benefit from this trend,
given their high proportion of revenue from these solutions -
Samuel 
    ** Says the solutions are meant to address the front-end of
care, such as intake and treating the patient, as well as the
back-end of care like billing, claims and coding
    ** Adds that this will allow care providers to focus on the
patient and reduce cost
    ** Up to Wednesday's close, HCAT down 43%, PHR down 57%, RCM
down 14.5% in the last 12 months, while OMCL up 19.3% 

 (Reporting by Dania Nadeem in Bengaluru)
 ((Dania.Nadeem@thomsonreuters.com;))

Recent news on Omnicell

See all news